Subscribe to RSS
DOI: 10.1055/a-0752-0217
A High Alanine Aminotransferase/Aspartate Aminotransferase Ratio Determines Insulin Resistance and Metabolically Healthy/Unhealthy Obesity in a General Adult Population in Korea: The Korean National Health and Nutritional Examination Survey 2007–2010
Publication History
received 22 June 2018
revised 26 September 2018
accepted 27 September 2018
Publication Date:
26 October 2018 (online)
![](https://www.thieme-connect.de/media/eced/201910/lookinside/thumbnails/06-2018-0270-dia_10-1055-a-0752-0217-1.jpg)
Abstract
Aims Early identification of individuals with insulin resistance (IR) and metabolically unhealthy state can help prevent various diseases and improve quality of life. In this study, we investigated a possible marker of IR and metabolic health status, alanine aminotransferase/aspartate aminotransferase (ALT/AST) ratio, and aimed to confirm its feasibility in a large population study.
Methods A total of 16,371 adults from Korean National Health and Examination Survey were studied. Participants were divided into four groups according to their ALT/AST ratio quartiles. The homeostatic model assessment of insulin resistance level and proportion of people with IR, impaired fasting glucose, and undiagnosed type 2 diabetes were compared for each group. Receiver-operating characteristics (ROC) curve was also used to assess the usefulness of ALT/AST ratio to identify individuals with IR and metabolically unhealthy.
Results In the groups with higher ALT/AST ratio, HOMA-IR level, proportion of IR, and proportion of individuals with IFG or type 2 diabetes mellitus was higher than that in those with low ALT/AST ratio. When analyzed with other factors related to IR, the data showed that the ALT/AST ratio was an independent predictor of IR (odds ratio 1.363, 95% confidential interval 1.323–1.405, p<0.001). When ROC curve analysis was done, area under curve (AUC) for identifying individuals with IR was 0.634. In addition, metabolically unhealthy individuals showed significantly higher ALT/AST ratio than metabolically healthy individuals (0.9780 vs 0.8511, p<0.001).
Conclusions ALT/AST ratio was well-correlated with IR, IR-related conditions, and metabolic health status. This easily accessible method to estimate IR may facilitate the early screening of IR, which can result in prevention of IR-related morbid conditions.
Supplementary Material
- Supplementary material Table S1 Online content
viewable at https://doi.org/10.1055/a-0752-0217
- Supplementary Material
-
References
- 1 Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia. 2003; 46: 3-19
- 2 Meshkani R, Adeli K. Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. Clin Biochem. 2009; 42: 1331-1346
- 3 Utzschneider KM, Kahn SE. Review: The role of insulin resistance in nonalcoholic fatty liver disease. J Clin Endocrinol Metab 2006; 91: 4753-4761
- 4 Hawley JA. Exercise as a therapeutic intervention for the prevention and treatment of insulin resistance. Diabetes Metab Res Rev 2004; 20: 383-393
- 5 Durbin RJ. Thiazolidinedione therapy in the prevention/delay of type 2 diabetes in patients with impaired glucose tolerance and insulin resistance. Diabetes Obes Metab 2004; 6: 280-285
- 6 Kim JK, Kim YJ, Fillmore JJ. et al. Prevention of fat-induced insulin resistance by salicylate. J Clin Invest 2001; 108: 437-446
- 7 Singh B, Saxena A. Surrogate markers of insulin resistance: A review. World J Diabetes 2010; 1: 36-47
- 8 Kang B, Yang Y, Lee EY. et al. Triglycerides/glucose index is a useful surrogate marker of insulin resistance among adolescents. Int J Obes (Lond) 2017; 41: 789-792
- 9 He J, He S, Liu K. et al. The TG/HDL-C ratio might be a surrogate for insulin resistance in chinese nonobese women. Int J Endocrinol 2014; 2014: 105168
- 10 Kawamoto R, Kohara K, Kusunoki T. et al. Alanine aminotransferase/aspartate aminotransferase ratio is the best surrogate marker for insulin resistance in non-obese Japanese adults. Cardiovasc Diabetol. 2012; 11: 117
- 11 Radziuk J. Insulin sensitivity and its measurement: structural commonalities among the methods. J Clin Endocrinol Metab 2000; 85: 4426-4433
- 12 Bonnet F, Ducluzeau PH, Gastaldelli A. et al. Liver enzymes are associated with hepatic insulin resistance, insulin secretion, and glucagon concentration in healthy men and women. Diabetes. 2011; 60: 1660-1667
- 13 Gomez-Samano MA, Cuevas-Ramos D, Mehta R. et al. Association of Alanine Aminotransferase Levels (ALT) with the Hepatic Insulin Resistance Index (HIRI): A cross-sectional study. BMC Endocr Disord 2012; 12: 16
- 14 Wu P, Chen Q, Chen L. et al. Dose-Response relationship between alanine aminotransferase levels within the reference interval and metabolic syndrome in chinese adults. Yonsei medical journal 2017; 58: 158-164
- 15 Stefan N, Haring H, Schulze M. Metabolically healthy obesity: The low-hanging fruit in obesity treatment?. Lancet Diabetes Endocrinol 2018; 6: 249-258
- 16 Stefan N, Schick F, Haring H. Causes, Characteristics, and Consequences of Metabolically Unhealthy Normal Weight in Humans. Cell Metab. 2017; 26: 292-300
- 17 Organization WH. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications Australia; 2000
- 18 Kwon SS, Lee SG, Lee YH. et al. Homeostasis model assessment of insulin resistance in a general adult population in Korea: additive association of sarcopenia and obesity with insulin resistance. Clin Endocrinol (Oxf) 2017; 86: 44-51
- 19 DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214-E223
- 20 Laakso M. How good a marker is insulin level for insulin resistance?. Am J Epidemiol 1993; 137: 959-965
- 21 Marcovina S, Bowsher RR, Miller WG. et al. Standardization of insulin immunoassays: report of the American Diabetes Association Workgroup. Clin Chem. 2007; 53: 711-716
- 22 Song Y, Manson JE, Tinker L. et al. Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women: The Women’s Health Initiative Observational Study. Diabetes Care. 2007; 30: 1747-1752
- 23 Haffner SM, Kennedy E, Gonzalez C. et al. A prospective analysis of the HOMA model. The Mexico City Diabetes Study. Diabetes Care. 1996; 19: 1138-1141
- 24 Ikeda Y, Suehiro T, Nakamura T. et al. Clinical significance of the insulin resistance index as assessed by homeostasis model assessment. Endocr J. 2001; 48: 81-86
- 25 Gayoso-Diz P, Otero-Gonzalez A, Rodriguez-Alvarez MX. et al. Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: Effect of gender and age: EPIRCE cross-sectional study. BMC Endocr Disord 2013; 13: 47
- 26 Gayoso-Diz P, Otero-Gonzalez A, Rodriguez-Alvarez MX. et al. Insulin resistance index (HOMA-IR) levels in a general adult population: Curves percentile by gender and age. The EPIRCE study. Diabetes Res Clin Pract 2011; 94: 146-155
- 27 Ioannou GN, Bryson CL, Boyko EJ. Prevalence and trends of insulin resistance, impaired fasting glucose, and diabetes. J Diabetes Complications 2007; 21: 363-370
- 28 Yamada C, Mitsuhashi T, Hiratsuka N. et al. Optimal reference interval for homeostasis model assessment of insulin resistance in a Japanese population. J Diabetes Investig 2011; 2: 373-376
- 29 Felig P. The glucose-alanine cycle. Metabolism. 1973; 22: 179-207
- 30 Yamada C, Kondo M, Kishimoto N. et al. Association between insulin resistance and plasma amino acid profile in non-diabetic Japanese subjects. J Diabetes Investig 2015; 6: 408-415
- 31 Yamakado M, Tanaka T, Nagao K. et al. Plasma amino acid profile is associated with visceral fat accumulation in obese Japanese subjects. Clin Obes 2012; 2: 29-40
- 32 Lakka TA, Lakka HM, Salonen R. et al. Abdominal obesity is associated with accelerated progression of carotid atherosclerosis in men. Atherosclerosis. 2001; 154: 497-504
- 33 Karelis AD, St-Pierre DH, Conus F. et al. Metabolic and body composition factors in subgroups of obesity: What do we know?. J Clin Endocrinol Metab 2004; 89: 2569-2575
- 34 McLaughlin T, Abbasi F, Lamendola C. et al. Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivity. Arch Intern Med 2007; 167: 642-648